Satellos Bioscience names new chief medical officer

• Healthcare

• Satellos Bioscience (TSX:MSCL:CA) appointed Wildon Farwell, M.D., MPH, as chief medical officer.
• Dr. Farwell joins Satellos from Dyne Therapeutics (DYN), where he most recently served as CMO and medical advisor.
• Dr. Farwell succeeds Jordan Dubow, MD, who has served as Satellos’ part-time CMO since January 2024.
• Dr. Dubow will continue to serve as a consultant to Satellos and chair of its Clinical Advisory Board.

More on Satellos Bioscience Inc.

• Historical earnings data for Satellos Bioscience Inc.
• Financial information for Satellos Bioscience Inc.